Lime aims to eliminate aging-related ailments by using its carbon nanosensor-based platform for lipid-targeting drug discovery. Lipid dysfunction is a driver of diseases throughout the body, but a screening platform to identify new targets and therapies to reverse this dysfunction has not existed up until now. Our diversified business model is driven by (a) revenue generation via pharma company partnerships, and (b) internal drug development.